| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69452-193-20 | 69452-193 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20191214 | N/A | ANDA | ANDA212799 | Bionpharma Inc. | POTASSIUM CITRATE | 10 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-193-20) |
| 69452-193-30 | 69452-193 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20191214 | N/A | ANDA | ANDA212799 | Bionpharma Inc. | POTASSIUM CITRATE | 10 meq/1 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-193-30) |
| 69452-194-20 | 69452-194 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20191214 | N/A | ANDA | ANDA212799 | Bionpharma Inc. | POTASSIUM CITRATE | 15 meq/1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-194-20) |
| 69452-194-30 | 69452-194 | HUMAN PRESCRIPTION DRUG | Potassium Citrate | Potassium Citrate | TABLET, EXTENDED RELEASE | ORAL | 20191214 | N/A | ANDA | ANDA212799 | Bionpharma Inc. | POTASSIUM CITRATE | 15 meq/1 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69452-194-30) |